Literature DB >> 17337142

Laryngeal solitary fibrous tumour.

Francesco Stomeo1, Davide Padovani, Corrado Bozzo, Antonio Pastore.   

Abstract

Solitary fibrous tumours (SFT) are rare neoplasms, with an uncommon laryngeal involvement. Only five cases of laryngeal localization have been described in literature. The following is a case of a 75-year-old man with a supraglottic neoplasm of the larynx; after the biopsy immunohistochemical study demonstrated a strong positivity for vimentin, CD34 and Bcl-2. The neoplasm was consequently classified as a SFT. CO(2) laser surgery of the supraglottic larynx, with a wide excision of the neoplasm, was performed. Twenty-four months on, the patient is alive, well and free of disease. Surgical resection is the treatment of choice for laryngeal SFT, but tumour-free resection margins must be achieved to prevent the possibility of local recurrence. Endoscopic resection by means of the CO(2) laser must be accurately planned with MRI or CT imaging to confirm of this kind of surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337142     DOI: 10.1016/j.anl.2007.01.001

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  4 in total

1.  Solitary fibrous tumor of the larynx.

Authors:  Lester D R Thompson; Yevgeniy Karamurzin; Mark Li-cheng Wu; Jason H Kim
Journal:  Head Neck Pathol       Date:  2008-03-15

2.  CT, MR, and angiography findings of a solitary fibrous tumor of the larynx: a case report.

Authors:  Suk Ki Chang; Dae Young Yoon; Chul Soon Choi; Eun Joo Yun; Young Lan Seo; Eun Suk Nam
Journal:  Korean J Radiol       Date:  2008 Nov-Dec       Impact factor: 3.500

3.  [An exceptional tumor of the finger: the solitary fibrous tumor].

Authors:  Taoufiq Harmouch; Nawal Hamas; Abdelkrim Daoudi; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2011-12-01

4.  Solitary fibrous tumour of the supraglottic larynx.

Authors:  A Grammatica; A Bolzoni Villaret; M Ravanelli; P Nicolai
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12-29       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.